Skip to main content
. 2017 May 15;13(5):615–629. doi: 10.7150/ijbs.17051

Table 2.

Association between FTO SNPs and related diseases

FTO single nucleotide polymorphisms Date Study samples region Related diseases Ref.
rs1421085 (T/C) 2013 2,077 T2DM patients and 3,085 healthy people (clinic-based) European decreased insulin sensitivity index (P = 0.007)
T2DM ( P = 0.001)
[32]
2013 10447 men and women (population-based) African American and European decline in cognitive function, assessed by performance on the Delayed Word Recall Test (P = 0.002) [33]
rs9939609(T/A) 2011 3,919 T2D patients and 4,172 healthy people (clinic-based) South Asian increased chances of T2DM ( P = 10-8) [34]
2012 2,858 PCOS patients and 2,358 healthy people (clinic-based) Asian T2DM ( P = 6 x 10-8)
polycystic ovary syndrome( P = 1.3 x 10-11)
[35]
2009 37,927 men and women (population-based) European increased systolic ( P = 4 x 10-5)
increased diastolic blood pressure (P = 0.003)
increased chances of hypertension ( P = 2 x 10-4)
[36]
2012 2,816 patients and 2,932 healthy people (clinic-based) European and Asian increased chances of pancreatic cancer [37]
rs8050136(C/A) 2012 6,835 men and women (population-based) American Indian lower eGFR (P = 0.002) [38]
2010 21,674 women (population-based) European increased risk of cardiovascular disease [39]
rs8044769 2013 9764 OA patients and 5362 healthy people (clinic-based) European increased chances of knee osteoarthritis risk and body mass index [40]
2016 196 OA cases and 442 healthy people (clinic-based) Chinese not modify individual susceptibility to osteoarthritis (P = 0.791) [41]
rs11075995 rs9939609
rs17817449(T/G) rs8050136(C/A) rs1477196 rs6499640 rs16953002 rs1121980(T/C)
2015 an overview African American and European increased chances of ER-negative breast cancer [42, 43]
rs16953002 2013 12,313 patients and 55,667 healthy people (clinic-based) European Increased chances of melanoma (P = 4 x 10-12) [44]

abbreviations: e-GFR, estimated glomerular filtration rate; ER, estrogen receptor; T2DM, type 2 diabetes mellitus

HHS Vulnerability Disclosure